The reality: Injectables Still set the efficacy ceiling Strongest outcomes + label support Oral drugs Lower efficacy (~1113%) But expand the market significantly Key insight: This is not one oral category Oral semaglutide requires fasting + waiting Orforglipron taken anytime The winner may be the least inconvenient drug, not the most effective The Hidden Problem: Persistence This is the part almost no one talks about: Only ~24.5% of patients remain on therapy at 12 months ~20% switch therapies within a year After stopping: Weight regain 0.8 kg per month Let that sink in
Some of the inconsistency across preclinical reports reflects differences in the compounds, doses, and assay conditions used, so standardised reporting of peptide characterisation and experimental conditions would make the literature easier to interpret and to replicate
Retrieved February 28, 2014
Static measurements to determine rates of insulin secretion, glucagon secretion, and cAMP release Rates of insulin, glucagon, and cAMP release were determined statically under multiple conditions as previously described 82
Revisa siempre el etiquetado del producto antes de su uso, especialmente composicin, alrgenos, modo de empleo, dosis recomendada y advertencias especficas indicadas por el fabricante
&srotate=0)
